PHARMACY

Amneal launches generic lidocaine ointment

BY David Salazar

BRIDGEWATER, N.J. — Amneal Pharmaceuticals this week launched a new lidocaine product line with the availability of its lidocaine 5% ointment. The company said that it hopes to expand the line with a transdermal patch formulation, which is currently waiting for final approval from the Food and Drug Administration. 
 
“Lidocaine ointment is our third topical medication and, once approved, the patch will be our first transdermal product,” Amneal’s EVP sales and marketing Jim Luce said.  “These two additions to our portfolio demonstrate our commitment to expand into new, more complex dosage forms valued by our pharmacy customers and their patients.”
 
The annual sales for lidocaine ointment in the United States were $251 million for the year ending September 2015, according to IMS Health data. The cream will be available in a 50-g jar and a 35.44-g tube with a child-resistant cap. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Teva launches generic Actiq

BY DSN STAFF

NORTH WALES, Pa. — Teva Pharmaceuticals on Wednesday announced the launch of its new generic of Actiq (fentanyl citrate) oral transmucosal lozenges.
 
The lozenges are indicated to manage breakthrough pain in cancer patients 16 years old and older who are currently receiving and tolerating around-the-clock opioid medicine. They are contraindicated in patients who are not tolerant of opioids, management of acute or postoperative pain and patients sensitive to any of the drug’s ingredients.  
 
Teva’s lozenges will be available in 200-, 400-, 600-, 800-, 1200-, and 1600-mcg dosage strengths. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS’ Anderson, Arthritis Foundation’s Palmer pen MTM op-ed

BY DSN STAFF

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?